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Recent studies, as summarized in this brief review, 
show that different factors regulate the biosynthesis of 
20- versus 22-carbon (n-6) and (n-3) polyunsaturated 
fatty acids. It is generally accepted that dietary linoleic 
and linolenic acids are metabolized to arachidonic acid 
and 20:5(n-3) respectively in the endoplasmic reticulum 
as follows: 
9,12-18:2 ---> 6,9,12-18:3 --~ 8,11,14-20:3 ---> 
5,8,11,14-20:4 
9,12,15-18:3 --~ 6,9,12,15-18:4 --> 8,11,14,17-20:4 
--+ 5,8,11,14,17-20:5 
The incorporation of (n-3) versus (n-6) fatty acids into 
membrane lipids is regulated by a number of different 
processes within the cell. It is generally accepted that a 
common 6-desaturase uses both linoleate and linolenate 
as substrates. Desaturation of linoleate and linolenate are 
generally considered to be the rate limiting steps in the 
biosynthesis of arachidonate and 20:5(n-3) respectively 
(1). The addition of fatty acids to the diet, beyond the 
rate limiting 6-desaturation step, would thus appear to 
be a way to increase the amount of arachidonate or 
20:5(n-3) that is produced and potentially made avail- 
able for esterification into membrane lipids. 
In order to evaluate this hypothesis, we carried out a 
number of feeding studies with deuterium labeled (n-6) 
fatty acids using the following general protocol. Male 
weanling Sprague-Dawley rats were maintained on a 
modified AIN diet that contained 3.3% fat the composi- 
tion of which was 2.1% oleate, 1.0% linoleate and 0.2% 
linolenate. After 4 weeks on this diet, the animals were 
changed to one in which all of the linoleate was replaced 
by 17,17,18,18-d4 linoleate. After 4 days the animals 
were sacrificed and it was observed that 34 mol % of 
arachidonate esterifed in liver phospholipids was derived 
from the deuterium labeled linoleic acid. Another group 
of animals was maintained on the AIN diet that con- 
tained 1.9% oleate, 1% linoleate, 0.2% linolenate and in 
addition 0.2% ethyl 18:3(n-6). Again, all of the linoleate 
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was replaced by d4-1inoleate but now only 27% of the 
esterified 20:4(n-6) was derived from the labeled precursor. 
The same above protocol was now repeated except that 
17,17,18,18-d4-18:3(n-6) replaced the unlabeled 18:3 
(n-6). Now 25% of the arachidonate esterifed in liver 
phospholipids was derived from the d4-18:3(n-6). The 
absolute amount of arachidonate in liver phospholipids 
was the same when animals were fed on diets with and 
without 18:3(n-6). By adding the amount of deuterium 
labeled arachidonate esterified in phospholipid from the 
latter two groups; i.e. 27% plus 25% it is apparent that 
52 tool % of the esterified arachidonate was derived 
from 18:2(n-6) and 18:3(n-6). This value of 52% corre- 
sponds to only 34% when linoleate was the only dietary 
(n-6) fatty acid. 
Addition of 18:3(n-6) to the diet resulted in the syn- 
thesis of more esterified 20:4(n-6) without altering 
the mass amount of 20:4(n-6) in liver phospholipid. The 
implication of this finding is that dietary supplements of 
18:3(n-6) may possibly increase the amount of 20:4(n-6) 
in the free fatty acid pool. Secondly, dietary 18:3(n-6) 
may down regulate the activity of the 6-desaturase 
that metabolizes 18:2(n-6) to 18:3(n-6), however, this 
remains to be determined. If 18:3(n-6) does down regu- 
late 6-desaturase activity the effect is not unique for this 
(n-6) fatty acid since the addition of deuterium-labeled 
20:3(n-6) or 20:4(n-6) to the diet also depressed the 
amount of d4-18:2(n-6) that was metabolized to 20:4 
(n-6) and esterified into liver phospholipids. 
When animals are maintained on a chow diet, the liver 
phospholipids contain linoleate and arachidonate but 
only low levels of 18:3(n-6) and 20:3(n-6). Liver lipids 
of rats fed chow contain low levels of all 18- and 20- 
carbon (n-3) fatty acids. These compositional differ- 
ences have never been explained by specificities for any 
single process. Rates of reactions for desaturation and 
chain elongation are similar for analogous substrates 
from the two families of fatty acids (2), as are rates of 
acylation using 1-acyl-sn-glycero-3-phosphocholine as 
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an acceptor (3). Several other processes, which have not 
as yet been examined in detail, may play a role in regu- 
lating membrane lipid fatty acid composition. In general, 
diets contain much higher levels of linoleate than 
linolenate. Higher intracellular levels of linoleate than 
linolenate may in part explain why membrane lipids 
contain large amounts of esterified linoleate but little 
18:3(n-3). Alternatively, or in addition, there may be 
differences as to how linoleate and linolenate partition 
themselves between anabolic and catabolic pathways. If 
linolenate was a better substrate for ~-oxidation than was 
linoleate, the possibility exists that it could be selectively 
channeled into the 13-oxidation pathway rather than 
being used for polyunsaturated fatty acid biosynthesis. 
Peroxisomes ~-oxidize t8:3(n-3) somewhat more rapidly 
than they do linoleate (4). However, it remains to be 
determined how linoleate and linolenate distribute them- 
selves between mitochondria and peroxisomes for [3- 
oxidation. 
Once 18:3(n-6) and 18:4(n-3) are produced, are they 
channeled to longer chain fatty acids in such a way that 
they and their chain elongation products, i.e. 20:3(n-6) 
and 20:4(n-3) in essence are not being made available 
for acylation into membrane lipids in vivo? When 
[1-14C]18:3(n-6) and [1-14C]18:4(n-3) were incubated 
with hepatocytes these two acids were initially esterified 
into membrane phospholipids. However, during the 2 h 
incubation both acids were released from membrane 
phospholipids for subsequent metabolism to longer chain 
(n-6) and (n-3) acids (5). We suggested that hepatocytes 
might contain a phospholipase A2 which was specific 
for certain phospholipid molecular species to rapidly 
release 18:3(n-6) and 18:4(n-3) after they were esteri- 
fled. However, other studies have shown that fatty acids 
are released directly from rat microsomal lipids by trans- 
fer to CoA via an ATP-independent mechanism (6). If 
this pathway was highly fatty acid specific then acids 
such as 18:3(n-6) and 18:4(n-3) might initially be incor- 
porated into membrane phospholipids. They could then 
rapidly be released to CoA to yield the acyl-CoA which 
is the true substrate for malonyl-CoA dependent chain 
elongation (7). Further studies are obviously required 
to evaluate the validity of this hypothesis. 
Once arachidonate and 20:5(n-3) are produced then a 
complex type of intracellular communication must play 
a role in determining what regulates their metabolism to 
22:5(n-6) and 22:6(n-3) respectively. We recently showed 
that 22:5(n-3) was the precursor of 22:6(n-3) but the 
pathway was independent of a 4-desaturase and pro- 
ceeded as follows: 22:5(n-3) --~ 24:5(n-3) ~ 24:6 (n-3) 
22:6(n-3) (8). An analogous pathway operates for 
metabolizing 22:4(n-6) to 22:5(n-6). In these two 
reaction sequences the first two reactions take place in 
the endoplasmic reticulum while the partial [3-oxidation 
process, i.e. 24:5(n-6) ~ 22:5(n-6) and 24:6(n-3) 
22:6(n-3) probably takes place in peroxisomes (9, 10). 
The Figure shows revised pathways of (n-6) and (n-3) 
polyunsaturated fatty acid biosynthesis. In this Figure 
the solid arrows depict reactions taking place in the 
endoplasmic reticulum while the dashed arrows show 
(n-3) Pathway 
9 , 1 2 , 1 5 , - 1 8 : 3  ) . 6 ,9 ,12 ,15 , -18 :4  ) . 8 ,11 ,14 ,17 -20 :4  
) . 5 ,8 ,11 ,14 ,17 , -20 :5  ~ ~ .7 ,10 ,13 ,16 ,19 , -22:5  ~'- - -  ~ 9 , 1 2 , 1 5 , 1 8 , 2 1 - 2 4 : 5  
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(n-6) Pathway 
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~. 5 , 8 , 1 1 , 1 4 - 2 0 : 4  <'- - -  -'~ 7 , 1 0 , 1 3 , 1 6 - 2 2 : 4  e-- - -  ~ 9 , 1 2 , 1 5 , 1 8 - 2 4 : 4  
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Figure Revised pathways of (n-3) and (n-6) polyunsaturated fatty acid biosynthesis. The solid arrows denote 
reactions taking place in the endoplasmic reticulum while the dashed arrows show acids that are substrates for partial 
B-oxidation. 
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partial  ~-oxidat ion  react ions that most  l ikely take place 
in peroxisomes.  These revised pathways  of  polyunsa tu-  
rated fatty acid biosynthes is  raise three new, as yet, 
unanswered  questions.  Wha t  regulates the intracel lular  
m o v e m e n t  of fatty acids be tween  the endoplasmic  
re t icu lum and a site for partial  ~-oxidat ion? Secondly,  
both 24:4(n-6)  and 24:5(n-3)  are substrates for desatura- 
t ion at posi t ion 6. Does the endoplasmic  re t icu lum 
conta in  chain  length specific 6-desaturases? In  a series 
of compet i t ive  substrate studies we were not  able to 
obta in  any evidence  for mul t ip le  forms of a 6-desaturase 
(11). However ,  there is clearly a need to purify this 
enzyme  or enzymes  to conclus ive ly  answer  the above 
question.  Thirdly,  does the endoplasmic  re t icu lum con-  
tain mul t ip le  chain  e longat ing  enzymes?  Evidence  has 
accumulated to suggest that different condensing enzymes 
use saturated versus unsaturated primers. Once [~-ketoacyl- 
CoAs are formed presumably  c o m m o n  enzymes  com- 
plete the chain e longat ion  process (12). Accord ing  to the 
revised pathways of  (n-3) and (n-6) P U F A  biosynthesis  
six different acids mus t  be  chain elongated as l inoleate  
and l inolenate  are metabol ized  respect ively to 22:5(n-6)  
and 22:6(n-3).  It  would  seem unl ike ly  that a s ingle 
condens ing  enzyme  would  recognize  six different 
substrates. In  any case, the regulat ion of  the chain elon- 
gat ion process and the n u m b e r  of  enzymes  required may  
well  be  different  in  l iver versus in m a n y  extrahepatic 
t issues where  m e m b r a n e  lipid conta in  small  amounts  of  
unsaturated acids with 4, 5, or 6 double  bonds  with up 
to 36 carbon atoms (13). 
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